Company news

TransMedics Group, Inc. news in 2026

TransMedics Group, Inc.'s news releases, calls and decks from 2026, newest first.

View company

TransMedics Reports Third Quarter 2026 Financial Results

November 5, 2026

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

October 30, 2026

TransMedics to Present at Upcoming Investor Conferences

October 29, 2026

TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026

October 22, 2026

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook

September 10, 2026

TransMedics Reports Second Quarter 2026 Financial Results

August 4, 2026

TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference

July 28, 2026

TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026

July 21, 2026

TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH

July 6, 2026

Normothermic Machine Perfusion Market is Going to Booming Growth 2026-2033 | TransMedics Group Inc, OrganOx Limited

May 7, 2026

TransMedics Reports First Quarter 2026 Financial Results

May 5, 2026

TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH

April 29, 2026

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

April 23, 2026

TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

April 21, 2026

TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results

February 26, 2026

TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 10, 2026

TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

February 9, 2026

BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park

January 12, 2026

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

January 12, 2026

Calls in 2026

Decks in 2026